APO vs FHI

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 23, 2026

APO

69.0
AI Score
VS
APO Wins

FHI

59.6
AI Score

Investment Advisor Scores

APO

69score
Recommendation
HOLD

FHI

60score
Recommendation
STRONG BUY

AI Analyst Insights

Detailed Metrics Comparison

Metric APO FHI Winner
Forward P/E 11.6959 9.9206 FHI
PEG Ratio 0.4661 1.3978 APO
Revenue Growth 63.8% 18.3% APO
Earnings Growth 63.7% 19.3% APO
Tradestie Score 69.0/100 59.6/100 APO
Profit Margin 5.3% 21.3% FHI
Beta 1.00 1.00 Tie
AI Recommendation HOLD STRONG BUY FHI

Relative Price Performance (Last 90 Days)

APO 1M: -7.7% · 3M: -6.3% FHI 1M: +0.2% · 3M: -0.4%

Current Technical Phase

APO

Markdown
Sell / avoid

Price below a falling SMA50 (slope -3.2%), weak momentum, RSI 43

RSI (14): 43.0 · Price: $114.83

FHI

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 54

RSI (14): 53.6 · Price: $57.67

Fundamentals Snapshot

Metric APO FHI
Market Cap — —
Forward P/E 10.8 9.7
Trailing P/E 40.0 10.4
Revenue (TTM) — —
Revenue Growth 0.6% 0.2%
Gross Margin 0.4% 0.7%
Operating Margin 0.2% 0.3%
EPS 2.79 5.37
Dividend Yield 0.02% 0.03%

Frequently Asked Questions

Based on our detailed analysis, APO is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.